Manhattan Associates - MANH Stock Forecast, Price & News

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Manhattan Associates in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" MANH shares.
View MANH analyst ratings or view top-rated stocks.

4 analysts have issued twelve-month price objectives for Manhattan Associates' shares. Their MANH share price forecasts range from $150.00 to $205.00. On average, they predict the company's share price to reach $178.75 in the next year. This suggests a possible upside of 37.3% from the stock's current price.
View analysts price targets for MANH or view top-rated stocks among Wall Street analysts.

Manhattan Associates' stock was trading at $155.49 at the beginning of the year. Since then, MANH stock has decreased by 16.3% and is now trading at $130.18.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, October 25th 2022.
View our MANH earnings forecast.

Manhattan Associates, Inc. (NASDAQ:MANH) released its quarterly earnings data on Tuesday, July, 26th. The software maker reported $0.69 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.53 by $0.16. Manhattan Associates had a trailing twelve-month return on equity of 51.87% and a net margin of 16.67%. During the same period in the previous year, the company posted $0.48 EPS.

Manhattan Associates issued an update on its third quarter 2022 earnings guidance on Thursday, August, 4th. The company provided earnings per share (EPS) guidance of $0.56-$0.58 for the period, compared to the consensus estimate of $0.56. The company issued revenue guidance of $183.00 million-$187.00 million, compared to the consensus revenue estimate of $184.47 million.

478 employees have rated Manhattan Associates Chief Executive Officer Eddie Capel on Glassdoor.com. Eddie Capel has an approval rating of 94% among the company's employees. This puts Eddie Capel in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Manhattan Associates investors own include Cisco Systems (CSCO), Broadcom (AVGO), Gilead Sciences (GILD), NIKE (NKE), Procter & Gamble (PG), Visa (V), AbbVie (ABBV), Activision Blizzard (ATVI), Pfizer (PFE) and QUALCOMM (QCOM).

Manhattan Associates trades on the NASDAQ under the ticker symbol "MANH."

Manhattan Associates' stock is owned by many different retail and institutional investors. Top institutional shareholders include Kayne Anderson Rudnick Investment Management LLC (4.17%), Price T Rowe Associates Inc. MD (3.51%), State Street Corp (2.69%), RGM Capital LLC (1.57%), FMR LLC (1.51%) and Goldman Sachs Group Inc. (1.31%). Insiders that own company stock include Bruce Richards, Deepak Raghavan, Eddie Capel, Edmond Eger, John J Huntz Jr, John J Huntz, Jr, Linda T Hollembaek, Robert G Howell, Thomas E Noonan, Thomas E Noonan and Topline Capital Partners, Lp.
View institutional ownership trends.

Shares of MANH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of MANH stock can currently be purchased for approximately $130.18.

Manhattan Associates (NASDAQ:MANH) has a market capitalization of $8.16 billion and generates $663.64 million in revenue each year. The software maker earns $110.47 million in net income (profit) each year or $1.86 on an earnings per share basis.

The company employs 3,600 workers across the globe.

Manhattan Associates' mailing address is 2300 WINDY RIDGE PARKWAY TENTH FLOOR, ATLANTA GA, 30339. The official website for the company is www.manh.com. The software maker can be reached via phone at (770) 955-7070, via email at mhumphries@manh.com, or via fax at 770-955-0302.